APPLICATION OF FISH TECHNIQUE ON TISSUE IN DIAGNOSIS AND TREATMENT OF LYMPHOMA

Nhung Nguyen Thi Cuc1, , Minh Nguyen Thanh Binh2, Vinh Pham Quang1,2
1 Trung tâm Huyết học và Truyền máu, Bệnh viện Bạch Mai
2 Trường Đại học Y Hà Nội

Author contact

Main Article Content

Abstract

Lymphoma is a malignant disease of lymphoid tissue. The disease is very diverse in manifestations and prognosis, so from 1832 until now, there have been many classifications and formulas established to classify and diagnose. In 2001, the World Health Organization (WHO) issued a classification of lymphomas that could be applied worldwide. And then this classification became more and more complete in 2008, being able to distinguish the nature of the cells as B or T lymphocytes. And in 2016, WHO added genetic characteristics to classify the groups. To diagnose and classify lymphoma patients according to the WHO 2016 classification tables, it is necessary to apply a number of testing techniques, of which the FISH technique on solid tissue specimens has a lot of value. Some abnormalities that can be detected by this technique are chromosome 14 (14q32), chromosome 2 (2p12), chromosome 22 (22q11) and some other locations. Chromosomal abnormalities associated with B cell proliferation are 14q32 (IGH), 3q27 (BCL6), 11q13(CCND1), 18q21.3 (BCL2), autosomal abnormalities associated with T cells are 14q11.2 (TCRA), 7q34 (TCRB), 7p14 (TCRG), 2q23 (ALK), reciprocal translocations such as t(8;14), t(8;22) and t(2;8)… However, when implementing the technique, there are also some difficulties in close coordination between specialties and patient samples, as well as the need to combine more staining methods to analyze results accurately.

Article Details

References

1. Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol Oncol. 2001;19(4):129-150.
2. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Program. 2009:523-531.
3. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390.
4. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720-1748.
5. Cho J. Basic immunohistochemistry for lymphoma diagnosis. Blood Res. 2022;57(Suppl 1):S55-S61.
6. Campbell LJ. Cytogenetics of lymphomas. Pathology. 2005;37(6):493-507.
7. Zordan A. Fluorescence in situ hybridization on formalin-fixed, paraffin-embedded tissue sections. Methods Mol Biol. 2011;730:189-202.
8. Huber D, Voith von Voithenberg L, Kaigala GV. Fluorescence in situ hybridization (FISH): History, limitations and what to expect from micro-scale FISH? Micro Nano Eng. 2018;1:15-24.
9. Goud KI, Dayakar S, Vijayalaxmi K, et al. Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay. Indian J Med Res. 2012;135(3):312-317.
10. Tang Z, Wang L, Tang G, et al. Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects. Int J Mol Sci. 2019;20(16):3939.